| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3474693 | Italian Journal of Medicine | 2012 | 12 Pages |
Abstract
The current evidence does not support the hypothesis that palliative chemotherapy improves survival and/or quality of life in CUP patients who do not fit into any of the favorable sub-sets. Therefore, only low-toxicity empirical chemotherapy regimens should be offered to patients with a good performance status, and quality of life issues should be given priority for any choice of treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Gianluca Airoldi,